Press Release

All press releases

Assignment of Phoma macrostoma Patents to Evologic Technologies

Her Majesty the Queen in Right of Canada, as represented by the Canadian Minister of Agriculture and Agri-Food (“AAFC”) and Evologic Technologies GmbH have entered into an assignment and licence agreement regarding the Phoma macrostoma technology.

Munich, January 12, 2021: AAFC, one of the major performers of agricultural research in Canada and Evologic Technologies GmbH, a fast growing SpinOff of the Technical University of Vienna in bioprocess platform technology have entered into an assignment and licence agreement to further develop, manufacture and commercialize the Phoma macrostoma technology as a broadleaved weed herbicide. After reviewing some encouraging preliminary results with the technology, Evologic Technologies GmbH acquired the rights to key AAFC Phoma macrostoma patents that will support the commercialization of an environmentally friendly bioherbicide.

In particular, the mycelium and/or spore of the fungus Phoma macrostoma comprise bioherbicidal activity. This selective herbicidal activity is commercially highly relevant in order to replace chemical herbicides to increase sustainability in agriculture. Evologic Technologies will apply its proprietary manufacturing technology to replace the current solid state based manufacturing process to overcome current challenges in unit economics and product stability.

Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH acted as legal advisor to Evologic Technologies GmbH. Dr Marco Stief and Tobias Matschke provided the legal advisory and Dr Kerstin Wolff the patent advisory services.

Press Contact

Dr. Eva Dörner

Partner

German Patent Attorney

European Patent Attorney

Representative before the UPC

Chemist

Dr. Marco Stief

Partner

Attorney-at-Law

LL.M. University of Chicago

Tobias Matschke

Principal

Attorney-at-Law

Certified IP Lawyer

Dr. Kerstin Wolff

Senior Associate

German Patent Attorney

European Patent Attorney

Representative before the UPC

Ph.D. Molecular Biology and Microbiology

About Maiwald

Maiwald is a leading law firm in the field of intellectual property rights. With approximately 240 employees in Munich and Düsseldorf, Maiwald comprehensively supports companies in securing, defending and enforcing their intellectual property rights. Clients include start-ups, small and medium-sized enterprises and industrial groups in a wide range of industries. Approximately 80 patent attorneys and attorneys-at-law work internationally for clients in the fields of pharmaceuticals & biotechnology, organic chemistry & polymers, inorganic chemistry & building materials, food & agriculture, electrical engineering & mechanical engineering, communication & information technology, mobility & energy, displays & light, measuring & process engineering as well as medical technology & imaging. Maiwald advises and represents clients with regard to patents & utility models, supplementary protection certificates, trademarks & designs, copyright law, competition & antitrust law, compliance, contract law, employee invention law, pharmaceutical law, data protection and plant variety protection. The magazine Managing Intellectual Property named Maiwald “European SPC/Patent Prosecution Firm of the Year 2021”, “European Cross-Border Patent Litigation Team of the Year 2021” and “German Impact Case of the Year 2021”.